Casey Eye Institute has a large complement of clinical and research faculty engaged in numerous projects who are eager to work with residents and fellows. The department provides support for statistician and research compliance officer. The residents have produced work in a variety of areas, including basic science, translational work, and clinical studies. The program provides limited dedicated time for research during the first year. There are exceptional research opportunities at Casey. Here is a small sampling:
David Huang, M.D., Ph.D.
Dr. Huang is the Peterson Professor of Ophthalmology, a Professor of Biomedical Engineering and the director of the Center for Ophthalmic Optics and Lasers. He is known for being a co-inventor of optical coherence tomography (OCT), and has been recognized as a fellow of the National Academy of Inventors, as the recipient of the Dr. David Epstein Award at ARVO and of the Champalimaud Award. He continues to lead the field with innovations in ophthalmic imaging. Recently, his group has pioneered the development and clinical application of optical coherence tomography angiography, which uses OCT technology to detect blood flow and produce 3-dimensional angiogram without requiring dye injection.
Michael Chiang, M.D.
Dr. Chiang is the Knowles Professor of Ophthalmology and Medical Informatics and Clinical Epidemiology at OHSU and Vice-Chair of Research (with John Morrison, M.D.) at Casey. His research work involves telemedicine for diagnosis of retinopathy of prematurity and other ophthalmic diseases, implementation and evaluation of electronic health record systems, and computer-based image analysis for clinical diagnosis. He is past chair of American Academy of Ophthalmology (AAO) Medical Information Technology Committee, and serves as a trustee-at-large of AAO.
Mark Pennesi, M.D., Ph.D.
Dr. Pennesi is the Director of Ophthalmic Genetics Division and a clinician scientist with a diverse set of tools including molecular biology, cell culture, electrophysiology, and optical imaging. His interests include gene therapy and multimodal imaging for inherited retinal degenerations.